Influenza vaccine as prevention for cardiovascular diseases: Possible molecular mechanism
Abstract
No abstract availableKeywords
Funding Information
- Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja (173001)
This publication has 52 references indexed in Scilit:
- Type I IFN Triggers RIG-I/TLR3/NLRP3-dependent Inflammasome Activation in Influenza A Virus Infected CellsPLOS Pathogens, 2013
- Heart rate variability in normal and pathological sleepFrontiers in Physiology, 2013
- Conserved Synthetic Peptides from the Hemagglutinin of Influenza Viruses Induce Broad Humoral and T-Cell Responses in a Pig ModelPLOS ONE, 2012
- Towards universal influenza vaccines?Philosophical Transactions of the Royal Society B: Biological Sciences, 2011
- Identification of hemagglutinin structural domain and polymorphisms which may modulate swine H1N1 interactions with human receptorBMC Structural Biology, 2009
- Characterization of conserved properties of hemagglutinin of H5N1 and human influenza viruses: possible consequences for therapy and infection controlBMC Structural Biology, 2009
- Endothelial Nitric Oxide Synthase Plays an Obligatory Role in the Late Phase of Ischemic Preconditioning by Activating the Protein Kinase Cε–p44/42 Mitogen-Activated Protein Kinase–pSer-Signal Transducers and Activators of Transcription1/3 PathwayCirculation, 2007
- Influenza Vaccination as Secondary Prevention for Cardiovascular DiseaseCirculation, 2006
- Survival kinases in ischemic preconditioning and postconditioningCardiovascular Research, 2006
- Simple General-Model PseudopotentialPhysical Review Letters, 1972